Page de couverture de Catalyst for Change: New QA Guidelines Create Opportunities for Innovation

Catalyst for Change: New QA Guidelines Create Opportunities for Innovation

Catalyst for Change: New QA Guidelines Create Opportunities for Innovation

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

 In the second episode of our three-part podcast series, “Secure Innovation: How Life Sciences Companies Can Safely Seize Opportunity,” we sit down with Robert Willman, Practice Lead for Quality & Regulatory Assurance in the Life Sciences Division at NTT Data, Kevin Thompson, Computer System Validation Manager at NTT Data, and Darren Geaney, Computer Systems Validation Specialist at Kneat Solutions, to discuss quality assurance as an essential part of the safe manufacturing and sale of pharmaceutical products. These experts will touch on new compliance requirements, the differences between risk-based vs. opportunity-based approach to compliance and quality assurance and the benefits of focusing QA efforts on impact to product and patient.
Pas encore de commentaire